Decrease of CD4+CD25+ regulatory T cells and TGF-β at early immune reconstitution is associated to the onset and severity of graft-versus-host disease following allogeneic haematogenesis stem cell transplantation

被引:74
作者
Li, Qing [2 ]
Zhai, Zhimin [1 ]
Xu, Xiucai [2 ]
Shen, Yuanyuan [1 ]
Zhang, Aimei [2 ]
Sun, Zimin [3 ]
Liu, Huilan [3 ]
Geng, Liangquan [3 ]
Wang, Yiping [4 ]
机构
[1] Anhui Med Univ, Affiliated Hosp 2, Dept Hematol, Hefei 230601, Peoples R China
[2] Anhui Med Univ, Affiliated Anhui Prov Hosp, Cent Lab, Med Res Ctr, Hefei 230601, Peoples R China
[3] Anhui Prov Hosp, Dept Hematol, Hefei, Peoples R China
[4] Univ Sydney, Western Clin Sch, Ctr Transplantat & Renal Res, Westmead, NSW 2145, Australia
基金
中国国家自然科学基金;
关键词
Regulatory T cells; aHSCT; Acute and chronic GVHD; EXPRESSION; RECIPIENTS; TOLERANCE; CORRELATE; DONORS;
D O I
10.1016/j.leukres.2010.03.017
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Graft-versus-host disease (GVHD) is a frequent and life threatening complication of allogeneic haematogenesis stem cell transplantation (aHSCT). The correlation of CD4(+)CD25(+) regulatory T cells (Tregs) in the patients after aHSCT to the occurrence and severity of acute and chronic GVHD (aGVHD and cGVHD) is not fully investigated. Here, we examined the levels of CD4(+)CD25(+) Tregs by assessment of CD4(+)CD25(high) and CD4(+)CD25(+)CD127(low) in peripheral blood, and the levels of serum TGF-beta and TNF-alpha in 56 patients at early immune reconstitution following aHSCT. Our data showed a significant reduction in the frequency of Tregs in patients with grades II-IV aGVHD and extensive cGVHD compared to healthy controls. Moreover, a decreased level of CD4(+)CD25(+) Tregs was correlated to increased severity of GVHD. The levels of CD4(+)CD25(+) Tregs in non-GVHD groups were however significantly higher than that in healthy controls. A significant decrease in the levels of TGF-beta and a significant increase the levels of TNF-alpha was also seen with increased severity of GVHD. This study suggested that measurement of CD4(+)CD25(+) Tregs along with serum TGF-beta and TNF-alpha at early immune reconstruction after aHSCT may indicate the onset and severity of both aGVHD and cGVHD. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1158 / 1168
页数:11
相关论文
共 32 条
[1]   Performance of a new clinical grading system for chronic graft-versus-host disease: a multicenter study [J].
Akpek, G ;
Lee, SJ ;
Flowers, ME ;
Pavletic, SZ ;
Arora, M ;
Lee, S ;
Piantadosi, S ;
Guthrie, KA ;
Lynch, JC ;
Takatu, A ;
Horowitz, MM ;
Antin, JH ;
Weisdorf, DJ ;
Martin, PJ ;
Vogelsang, GB .
BLOOD, 2003, 102 (03) :802-809
[2]   FOXP3 expression in peripheral blood rapidly recovers and lacks correlation with the occurrence of graft-versus-host disease after allogeneic stem cell transplantation [J].
Arimoto, Kazue ;
Kadowaki, Norimitsu ;
Ishikawa, Takayuk ;
Ichinohe, Tatsuo ;
Uchiyama, Takashi .
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2007, 85 (02) :154-162
[3]  
BEUTLER E, 2001, WILLIAMS HEMATOLOG B, P209
[4]   IL-10 and TGF-β induce alloreactive CD4+CD25- T cells to acquire regulatory cell function [J].
Chen, ZM ;
O'Shaughnessy, MJ ;
Gramaglia, I ;
Panoskaltsis-Mortari, A ;
Murphy, WJ ;
Narula, S ;
Roncarolo, MG ;
Blazar, BR .
BLOOD, 2003, 101 (12) :5076-5083
[5]   Chronic graft-versus-host disease is associated with increased numbers of peripheral blood CD4+CD25high regulatory T cells [J].
Clark, FJ ;
Gregg, R ;
Piper, K ;
Dunnion, D ;
Freeman, L ;
Griffiths, M ;
Begum, G ;
Mahendra, P ;
Craddock, C ;
Moss, P ;
Chakraverty, R .
BLOOD, 2004, 103 (06) :2410-2416
[6]   CD4+CD25+ immunoregulatory T cells:: New therapeutics for graft-versus-host disease [J].
Cohen, JL ;
Trenado, A ;
Vasey, D ;
Klatzmann, D ;
Salomon, BL .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (03) :401-406
[7]   IL-30 is required for regulatory T cells to mediate tolerance to alloantigens in vivo [J].
Hara, M ;
Kingsley, CI ;
Niimi, M ;
Read, S ;
Turvey, SE ;
Bushell, AR ;
Morris, PJ ;
Powrie, F ;
Wood, KJ .
JOURNAL OF IMMUNOLOGY, 2001, 166 (06) :3789-3796
[8]   Modulation of graft-versus-host disease: Role of regulatory T lymphocytes [J].
Hess, AD .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (01) :13-21
[9]   SERUM TUMOR NECROSIS FACTOR-ALPHA LEVELS IN ALLOGENEIC BONE-MARROW TRANSPLANT RECIPIENTS WITH ACUTE-LEUKEMIA [J].
HIROKAWA, M ;
TAKATSU, H ;
NIITSU, H ;
NISHINARI, T ;
NIMURA, T ;
ITOH, T ;
CHUBACHI, A ;
MIURA, I ;
YOSHIDA, K ;
ENDO, Y ;
MIURA, AB .
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 159 (03) :237-244
[10]   Donor-type CD4+CD25+ regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation [J].
Hoffmann, P ;
Ermann, J ;
Edinger, M ;
Fathman, CG ;
Strober, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (03) :389-399